Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Inc - QTRLY Net Loss Of $12.5 Million, Or $2.56 Loss Per Common Share

March 23 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS INC - QTRLY NET LOSS OF $12.5 MILLION, OR
$2.56
LOSS PER COMMON SHARE
    * AETERNA ZENTARIS INC - QTRLY TOTAL REVENUE OF $2.5 MILLION
VERSUS $1.0 MILLION

Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on COSCIENS Biopharma

See all news